Abstract:Liver cancer is a significant global health challenge, with hepatocellular carcinoma (HCC) being the most prevalent form, characterized by high incidence and mortality rates. Despite advances in targeted therapies and immunotherapies, the prognosis for advanced liver cancer remains poor. This underscores the urgent need for a deeper understanding of the molecular mechanisms underlying HCC to enable early detection and the development of novel therapeutic strategies. Post-translational modifications (PTMs) are crucial regulatory mechanisms in cellular biology, affecting protein functionality, interactions, and localization. These modifications, including phosphorylation, acetylation, methylation, ubiquitination, and glycosylation, occur after protein synthesis and play vital roles in various cellular processes. Recent advances in proteomics and molecular biology have highlighted the complex networks of PTMs, emphasizing their critical role in maintaining cellular homeostasis and disease pathogenesis. Dysregulation of PTMs has been associated with several malignant cellular processes in HCC, such as altered cell proliferation, migration, immune evasion, and metabolic reprogramming, contributing to tumor growth and metastasis. This review aims to provide a comprehensive understanding of the pathological mechanisms and clinical implications of various PTMs in liver cancer. By exploring the multifaceted interactions of PTMs and their impact on liver cancer progression, we highlight the potential of PTMs as biomarkers and therapeutic targets. The significance of this review lies in its potential to inform the development of novel therapeutic approaches and improve prognostic tools for early intervention in the fight against liver cancer.

Advances in post-translational modifications of proteins and cancer immunotherapy

Glycosylation in the Tumor Immune Response: the Bitter Side of Sweetness

Protein post-translational modifications in the regulation of cancer hallmarks

Novel post-translational modifications of protein by metabolites with immune responses and immune-related molecules in cancer immunotherapy

Post-Translational Modifications in Tumor-Associated Antigens as a Platform for Novel Immuno-Oncology Therapies

The role of protein post-translational modifications in prostate cancer

Role of UFMylation in tumorigenesis and cancer immunotherapy

Protein Posttranslational Modification in Stemness Remodeling and Its Emerging Role as a Novel Therapeutic Target in Gastrointestinal Cancers

Regulating tumor suppressor genes: post-translational modifications

The role of histone post-translational modifications in cancer and cancer immunity: functions, mechanisms and therapeutic implications

Regulation of ovarian cancer by protein post-translational modifications

Unconventional protein post-translational modifications: the helmsmen in breast cancer

Intricate effects of post-translational modifications in liver cancer: mechanisms to clinical applications

[Regulation of PD-L1 posttranslational modification and its application progress in tumor immunotherapy]

Anti-Tumor Potential of Post-Translational Modifications of PD-1

Post-translational Modification of PD-1: Potential Pathways for Cancer Immunotherapy

Post-translational Modification of PD-1: Potential Targets for Cancer Immunotherapy

Role of Post-Translational Modifications in Colorectal Cancer Metastasis

Uncovering the modified immunopeptidome reveals insights into principles of PTM-driven antigenicity

Targeting Post-Translational Modification of Transcription Factors As Cancer Therapy.

Lysine methylation modifications in tumor immunomodulation and immunotherapy: regulatory mechanisms and perspectives